Allegro Diagnostics

Allegro Diagnostics

Verified
Development of genomic tests to support the diagnosis and management of lung cancer.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$22—32m (Dealroom.co estimates Jul 2011.)
Maynard Iowa (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor investor investor

$0.0

round
investor

$0.0

round
investor investor investor

$0.0

round

N/A

Acquisition
Total Funding000k

Recent News about Allegro Diagnostics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.